WO2018069508A1

WO2018069508A1 - Photoactivable biocide and/or bactericidal materials and process for manufacturing such materials

Info

Publication number: WO2018069508A1
Application number: PCT/EP2017/076207
Authority: WO
Inventors: Thomas Berthelot; Vincent SOL
Original assignee: Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Current assignee: Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Priority date: 2016-10-14
Filing date: 2017-10-13
Publication date: 2018-04-19
Anticipated expiration: 2019-04-14
Also published as: EP3308646A1; EP3308646B1

Abstract

The present invention relates to the field of materials; preferably to surfaces having biocide and/or bactericidal properties. Especially the present invention relates to a photoactivable surfaces and/or materials able to deliver singular oxygen as bactericidal agent; and the process for preparing such materials, said process comprising: (i) preparing a solution of at least one arylazide functionalized-photosensitizer; (ii) contacting the solution obtained at step (i) and a unmodified support; and (iii) covalently grafting by an insertion reaction, the arylazide functionalized- photosensitizer deposited on the support at step (ii), said insertion reaction being carried out by a thermal activation and/or a UV irradiation activation.

Description

PHOTOACTIVABLE BIOCIDE AND/OR BACTERICIDAL MATERIALS AND PROCESS FOR MANUFACTURING SUCH MATERIALS

FIELD OF INVENTION The present invention relates to the field of materials; preferably to surfaces having biocide and/or bactericidal properties. Especially the present invention relates to a photoactivable surface and/or material able to deliver singular oxygen as bactericidal agent; and the process for preparing such materials.

BACKGROUND OF INVENTION

Biocide and/or bactericidal materials represents a huge public health issue impacting widespread fields such as medical field, environment and food industry. Consequently, it is of interest to develop efficient processes for providing such materials.

In this purpose, one of the most efficient approach is chemically grafting biocide and/or bactericidal agents at the surface of materials. This chemical way allows avoiding releasing biocide and/or bactericidal agents over time.

Since 1960's, the bactericidal properties of quaternary ammonium are known. These compounds feature low toxicity and do not induce skin inflammatory reactions. Abel et ah, reported that paper supports may be modified by DABCO (l,4-diazibicyclo[2.2.2]octane) and that he grafting of quaternary ammoniums on this support allowed to provide bactericidal materials.

Natural and synthetic polymers were also used as biocide and/or bactericidal agents. For instance, the free amino functions of chitosan may be protonated in a slightly acid medium and the resulting cationic chitosan can act as a quaternary ammonium salt (Rabea et al., Biomacromolecules, 2003, 4, 1457-1465).

Some polymerization techniques such as ATRP (Atom Transfer Radical Polymerization) or RAFT (Reversible Addition-Fragmentation chain Transfer polymerization) were also used for grafting biocide and/or bactericidal agents comprising quaternary ammoniums (Lee et al., Biomacromolecules, 2004, 5; 877-882; Roy et al., Biomacromolecules, 2008, 9; 91-99). However, the art shows that the bactericidal properties depend on the alkyl chain length of the grafted quaternary ammonium. Another way of interest is the preparation of renewable surfaces from N-halamine compounds. These compound have the advantage to feature both a large disinfection range and a bactericidal ability due to the oxidative property of the halamine bond (N-Cl). In this chemical process, the halogen atom of the halamine bond is transferred to the receptors of the targeted bacteria, causing their death. After killing microorganisms, the halamine bond may be renewed by a treatment by chloration (Kaminski et al., J. Pham. ScL, 1976, 65, 553).

The research community also focused its attention on photosensitizers. This class of bactericidal compounds has the particularity to produce reactive species (free radicals and/or singular oxygen) very toxic for living cells under irradiations in the visible spectrum. Indeed, at the beginning of 1980' s, Nitzan et al. and Jori et al. evidenced the concept of Photo- Antimicrobial Chemo Therapy (PACT) by showing that low amounts of porphyrin and light allows killing 99% of a bacteria culture after only 2h.

Then, photobactericidal surfaces were developed by the incorporation of a photosensitizer in a solid surface. For instance, Bezman et al. (Photochem. Photobiol. 1978, 28, 325-329) showed that E. Coli bacteria could be killed when contacted with polystyrene beads coated with a photosensitizer after light irradiation.

However, the main drawback of these processes for providing biocide and/or bactericidal materials is that these processes always require the functionalization of the support prior to the graft of the biocide and/or of the bactericidal agent. Furthermore, the processes of the art often need severe conditions (high temperature, use of carcinogenic, mutagenic or toxic to reproduction reagents, etc...) that are not compatible with industrialization. Thus, there is still a need for providing versatile and easier process of manufacturing biocide and/or bactericidal materials.

Surprisingly, the Applicant has evidenced an efficient process for manufacturing biocide and/or bactericidal materials comprising:

(i) preparing a solution of at least one arylazide functionalized-photosensitizer,

(ii) contacting the solution of step (i) and a unmodified support thereby resulting in depositing the arylazide functionalized-photosensitizer on the support; and

(iii) covalently grafting by an insertion reaction, the arylazide functionalized- photosensitizer deposited on the support at step (ii), said insertion reaction being carried out by a thermal activation and/or a UV irradiation activation.

Advantageously, the process of the invention is versatile and allows grafting a photosensitizer on a surface that has not been previously modified. Furthermore, the process of the invention is carried out in only one step, and without catalysts, contrary to the process of the art for which several steps are required.

SUMMARY

This invention thus relates to a process for manufacturing a biocide and/or bactericidal material comprising:

(i) preparing a solution of at least one arylazide functionalized-photosensitizer, (ii) contacting the solution obtained at step (i) and a unmodified support, thereby resulting in depositing the arylazide functionalized-photosensitizer on the support; and

According to one embodiment, the arylazide functionalized-photosensitizer is selected from the group of unmetalled arylazide functionalized-photosensitizer. According to one embodiment, the arylazide functionalized-photosensitizer is selected from tetrapyrrolic compounds such as porphyrins, chlorins, phthalocyanines, benzoporphyrins, bacteriochlorins, chlorophyll derivatives, corroles, texaphyrins, pheophorbides and bacteriopheophorbides; or non tetrapyrrolic compounds such as phenalenones, xanthenes, coumarins, psoralens, antraquinones, curcuminoids, phenothiazines and cyanines.

According to one embodiment, the arylazide functionalized-photosensitizer is selected from tetrapyrrolic compounds such as porphyrins, chlorins, phthalocyanines, benzoporphyrins, bacteriochlorins, chlorophyll derivatives, corroles, texaphyrins, pheophorbides and bacteriopheophorbides; or non tetrapyrrolic compounds such as phenalenones, xanthenes, coumarins, psoralens, antraquinones, curcuminoids, phenothiazines, bodipy and cyanines.

According to one embodiment, the arylazide functionalized-photosensitizer is selected from arylazide porphyrins. According to one embodiment, the concentration of the azide functionalized- photosensitizer solution ranges from more than 0 to 10 mg/mL; preferably, from 0.01 to 5 mg/mL; more preferably, from 0.1 to 1 mg/mL.

According to one embodiment, the solvent of the arylazide functionalized-photosensitizer solution is selected from polar solvent; preferably, is acetone or water. According to one embodiment, the unmodified support is selected from synthetic or natural polymer; preferably from a polymer selected from the group of polystyrene, polyacrylates, polymethacrylates, polyolefins, polyurethanes, polyacrylonitriles, polyamides, polyesters, polycarbonates, polyethers, polyimides, polyketones, polysiloxanes, polyepoxydes and their copolymers and/or mixtures thereof or cellulosic polymer, more preferably, the unmodified support is paper, cotton fabrics or polyethylene. According to one embodiment, the thermal activation of the insertion reaction is carried out at a temperature ranging from 100°C to 300°C; more preferably, from 200°C to 250°C.

According to one embodiment, the UV irradiation activation of the insertion reaction is carried out at a wavelength ranging from 10 nm to 400 nm; preferably, from 300 nm to 380 nm; more preferably, the wavelength is about 365 nm.

According to one embodiment, the UV irradiation activation of the insertion reaction is carried out during a time period ranging from 1 mn to 24h; preferably, the UV irradiation activation of the insertion reaction is carried out during a time period ranging from 1 min to 10 min.

The present invention also refers to a biocide and/or bactericidal material comprising:

(a) an unmodified support, preferably selected from synthetic or natural polymer, more preferably from paper, cotton fabrics or polyolefin; and

(b) at least one arylazide-functionalized photosensitizer; preferably selected from tetrapyrrolic compounds such as porphyrins, chlorins, phthalocyanines, benzoporphyrins, bacteriochlorins, chlorophyll derivatives, corroles, texaphyrins, pheophorbides and bacteriopheophorbides; or non tetrapyrrolic compounds such as phenalenones, xanthenes, coumarins, psoralens, antraquinones, curcuminoids, phenothiazines and cyanines; more preferably selected form porphyrins;

said arylazide-functionalized photosensitizer being covalently grafted to the support through an insertion bond.

According to one embodiment, the biocide and/or bactericidal material comprises:

(b) at least one arylazide-functionalized photosensitizer; preferably selected from tetrapyrrolic compounds such as porphyrins, chlorins, phthalocyanines, benzoporphyrins, bacteriochlorins, chlorophyll derivatives, corroles, texaphyrins, pheophorbides and bacteriopheophorbides; or non tetrapyrrolic compounds such as phenalenones, xanthenes, coumarins, psoralens, antraquinones, curcuminoids, phenothiazines, bodipy and cyanines; more preferably selected form porphyrins;

The present invention also refers to the use of the biocide and/or bactericidal material as defined above, in the preparation of clothes or coatings; preferably, in the preparation of protective clothes or protective coatings.

The present invention also refers to the use of the biocide and/or bactericidal material as defined above, in the decontamination of water and/or biological fluids and/or biological surfaces.

The present invention also refers to a kit comprising:

— in a first compartment, the unmodified support, preferably selected from synthetic or natural polymer, more preferably from paper, cotton fabrics or polyolefin; and

— in a second compartment, the solution comprising at least one arylazide-functionalized photosensitizer.

According to one embodiment, the solution comprising at least one arylazide-functionalized photosensitizer is protected from light.

DEFINITIONS

In the present invention, the following terms have the following meanings:

- "about": preceding a figure means plus or less 10% of the value of said figure;

- "derivatives": refers to any compounds resulting from the modification of a compound; especially, the derivative may differ from one or more atoms or functional groups;

- "biocide": refers to any used compound or material for killing, destroying, deterioring, rendering harmless, preventing the action or combating organisms; preferably unicellular organisms including for example, eukaryote cells or prokaryote cells. In one preferred embodiment, the organisms are selected from bacteria, fungi, virus and yeasts;

- "bactericidal": refers to any used compound or material intended to kill bacteria; - "azide": refers to the chemical functional group - N=N=N (or -N3);

- "arylazide": refers to the chemical functional group - X-N=N=N (or -X— N3) wherein X represents an aryl group which is selected from mono- or polycyclic system of 5 to 20, and preferably 6 to 12, carbon atoms having one or more aromatic rings (when there are two rings, it is called a biaryl) among which it is possible to cite the phenyl group, the biphenyl group, the 1-naphthyl group, the 2-naphthyl group, the tetrahydronaphthyl group, the indanyl group and the binaphthyl group. In the present invention, the term aryl also means any aromatic ring including at least one heteroatom chosen from an oxygen, nitrogen or sulfur atom. The aryl group can be substituted by 1 to 3 substituents chosen independently of one another, among a hydroxyl group, a linear or branched alkyl group comprising 1, 2, 3, 4, 5 or 6 carbon atoms, in particular methyl, ethyl, propyl, butyl, an alkoxy group or a halogen atom, in particular bromine, chlorine and iodine;

- "photosensitizer": refers to any molecules inducing a chemical change in another molecule in a photochemical process;

- "unmodified support": refers to any support that is not modified before the grafting step in order to introduce on the support suitable functions involved in the grafting process. Especially, in the present invention, the unmodified support refers to support used as such. According to one embodiment, the unmodified support is a raw support. According to one embodiment, the unmodified support is an unprocessed support; - "covalently grafting": refers to any grafting step that lead to a covalent bond between the molecule to be grafted (the photosensitizer) and the support;

- "insertion reaction": refers to a chemical reaction in which a compound fits into a bond of another compound. Especially, in the present invention, the function azide of the arylazide-functionalized photosensitizer fits into C-H bond and/or N-H bond of a support that was not previously modified. In the present invention, the insertion reaction requires the activation of the azide function by a thermal activation or by a UV irradiation activation. Advantageously, the aryl moiety of the function arylazide allows stabilizing the nitrene intermediate synthesized during the insertion reaction between arylazide-functionalized photosensitizer and the support that was not previously modified. This stabilization of the intermediate reaction is not obtained with an aliphatic azide;

- "insertion bond": refers to any single bond resulting from an insertion reaction as defined above;

- "thermal activation": refers to the action of temperature on an organic function involved in an insertion reaction;

- "UV irradiation activation": refers to the action of UV light on an organic function involved in an insertion reaction;

- "unme tailed": refers to any compound that does not comprise any chemical element selected from metals of the periodic table of elements;

- "metalled": refers to any compound that does comprise at least one chemical element selected from metals of the periodic table of the elements. Especially, the term "metalled" refers to any compound that does comprise at least one chemical element selected from alkali metals, alkaline earth metals, transition metals, lanthanoids, actinoids and poor metals. In the present invention, the term "metalled" preferably refers to any compound that does comprise at least one chemical element selected from zinc (Zn), manganese (Mn), silver (Ag), cobalt (Co), palladium (Pd), nickel (Ni), iron (Fe), copper (Cu) and Ytterbium (Yb); more preferably, zinc (Zn);

- "polar solvent": refers to any solvent having a nonzero dipole moment;

- "wavelength": refers to a physical value for characterizing monochromatic wave in the light spectra and is defined as the distance between two consecutive maxima of the wave amplitude;

- "protective": refers to any cloths or coatings that are able to protect from organisms; preferably from unicellular organisms including for example, eukaryote cells or prokaryote cells. In one preferred embodiment, the organisms are selected from bacteria, fungi, virus and yeasts;

- "tetrapyrrolic compounds": refers to any compounds having a structure derived from tetrapyrrole (i.e. molecules containing four pyrrole rings held together by direct covalent bonds or by one carbon bridges);

- "porphyrin": refers to any aromatic compounds having a structure derived from tetrapyrroles interconnected at their alpha-carbon atoms via methine bridges;

- "chlorin": refers to any heterocyclic aromatic rings comprising three pyrroles and one pyrroline cores linked together by methine bridge;

- "phthalocyanine": refers to any aromatic compounds comprising four isoindole rings linked together by imine bridge;

- "benzoporphyrin": refers to any aromatic compounds having the chemical structure of a porphyrin with one or more benzene rings fused to its pyrrole rings;

- "bacteriochlorin": refers to any aromatic compounds having the chemical structure of bacterial sourced chlorin, i.e. having two pyrrole groups in the main ring;

- "chlorophyl" or "chlorophyll": refers to any magnesium-containing chlorins;

- "corrole": refers to a macrocycle with four pyrrolic cycles linked together by three methane bridges between four pyrolles and one direct connection between two pyrroles; - "texaphyrin": refers to any compounds having the same chemical structure of porphyrin but in which the methine bridges are changed by imine bridges;

- "pheophorbide": refers to any product resulting from chlorophyll breakdown;

- "phenalenone or lH-phenalen-l-one or perinaphtenone" refers to a chemical compound of formula C₁₃H₈O or a derivative thereof;

- "xanthene": refers to a chemical compound of formula C13H10O or a derivative thereof; - "coumarin" or "l-benzopyrane-2-one": refers to a chemical compound of formula or a derivative thereof;

- "psoralen" or

refers to a chemical compound of fluorocoumarin family of formula

or a derivative thereof;

- "antraquinone" or "anthracenedione": refers to a chemical compound of formula

or a derivative thereof;

- "curcuminoid": refers to a chemical compound which is derivative from curcuma chemical structure or a derivative thereof;

- "phenothiazine": refers to a chemical compound of formula or a

derivative thereof;

- "bodipy": refers to any chemical compound belonging to dipyrromethene family with a disubstituted boron atom;

- "cyanine": refers to any chemical compound belonging to polymethine dye family.

DETAILED DESCRIPTION

As mentioned above, the present invention relates to a process for manufacturing a biocide and/or bactericidal material comprising or consisting of:

In the present invention, the "biocide and/or bactericidal" properties are studied in the conditions of AATCC (American Association of Textile Chemists and Colorists), Test Method 100-2004, that comprises the following steps:

(a) an infection step in which the material to be studied is contamined with organism, preferably with bacteria; (b) an incubation step;

(c) an extraction step in which organisms, preferably bacteria, are eluted from the materials of step (a); and

(d) an enumeration step in which the number of organisms, preferably bacteria, is determined and the percentage reduction by treated specimen is calculated.

In the conditions of AATCC test, the material is defined as having a total bactericidal and/or biocide effect when the percentage reduction of organisms by treated specimen is about 100% of the initial number of organisms of the contamined material.

In the conditions of AATCC test, the material is defined as having a partial bactericidal and/or biocide effect when the percentage reduction of organisms by treated specimen ranges from 50% to less than 100% of the initial number of organisms of the contamined material.

In the conditions of AATCC test, the material is defined as having no bactericidal and/or biocide effect when the percentage reduction of organisms by treated specimen ranges from 0% to less than 50% of the initial number of organisms of the contamined material.

In the present invention, biocide and/or bactericidal activity was measured against bacteria such as, but not limited to, Escherichia Coli, Bacillus thuringiensis (vegetative form and/or spore), Salmonella typhimurium, Yersinia pestis or Bacillus anthracis (vegetative form and/or spore). According to one embodiment, the process does not comprise a step of contacting the arylazide functionalized-photosensitizer with a polymer acting as a coating on the unmodified support. According to one embodiment, in the process of invention the arylazide functionalized-photosensitizer directly reacts with the unmodified support.

According to one embodiment, the arylazide functionalized-photosensitizer is selected from the group of arylazide functionalized-photosensitizer in which the photosensitizer is under the form of free base. In the present invention, the terms "free base" mean any chemical compound being a conjugate base form of an amine. According to one embodiment, the arylazide functionalized-photosensitizer is selected from the group of unmetalled arylazide functionalized-photosensitizer.

According to one embodiment, the arylazide functionalized-photosensitizer is selected from the group of metallized arylazide functionalized-photosensitizer. In one embodiment, the arylazide functionalized-photosensitizer comprises at least one chemical element selected from alkali metals, alkaline earth metals, transition metals, lanthanoids, actinoids and poor metals.

In one embodiment, the alkali metal is selected from lithium (Li), sodium (Na), potassium (K), rubidium (Rb), caesium (Cs) and Francium (Fr). In one embodiment, the alkaline earth metal is selected from beryllium (Be), magnesium (Mg), calcium (Ca), strontium (Sr), barium (Ba) and radium (Ra).

In one embodiment, the transition metal is selected from scandium (Sc), titanium (Ti), vanadium (Va), chromium (Cr), manganese (Mn), iron (Fe), cobalt (Co), nickel (Ni), copper (Cu), yttium (Y), zirconium (Zr), niobium (Nb), molybdenum (Mo), technetium (Tc), ruthenium (Ru), rhodium (Rh), palladium (Pd), silver (Ag), hafnium, (Hf), tantalum (Ta), tungsten (W), rhenium (Re), osmium (Os), iridium (Ir), platinum (Pt), gold (Au), rutherfordium (Rf), dubnium (Db), seaborgium (Sg), bhorium (Bh), hassium (Hs), meitnerium (Mt), damstadidium (Ds), roentgerium (Rg).

In one embodiment, the lanthanoid is selected from lanthanium (La), cerium (Ce), praseodymium (Pr), neodymium (Nd), promethium (Pm), samarium (Sm), europium (Eu), gadolinium (Gd), terbium (Tb), dysprosium (Dy), holmium (Ho), erbium (Er), thulium (Tm), Ytterbium (Yb) and lutetium (Lu).

In one embodiment, the actinoid is selected from actinium (Ac), thorium (Th), protactinium (Pa), uranium (U), neptunium (Np), plutonium (Pu), americium (Am), curium (Cm), berkelium (Bk), californium (Cf), einsteinium (Es), fermium (Fm), mendelevium (Md), nobelium (No) and lawrencium (Lr).

In one embodiment, the poor metal is selected from aluminium (Al), zinc (Zn), gallium (Ga), germanium (Ge), cadmium (Cd), indium (In), tin (Sn), antimony (Sb), mercury (Hg), thallium (Ti), lead (Pb), bismuth (Bi), polonium (Po), inunbium (Uub), ununtrium (Uut), ununpentium (Uup), ununhexium (Uuh) and ununseptium (Uus); preferably, the poor metal is selected from aluminium (Al), zinc (Zn), gallium (Ga), germanium (Ge), cadmium (Cd), indium (In), tin (Sn), antimony (Sb), mercury (Hg), thallium (Ti), lead (Pb), bismuth (Bi), polonium (Po). In one embodiment, the poor metal is zinc (Zn).

According to one preferred embodiment, the metalled arylazide functionalized- photosensitizer comprises a metal which does not prevent the production of singlet oxygen and/or reactive oxygen species (ROS) by the photosensitizer of the invention. In one embodiment, the arylazide functionalized-photosensitizer comprises at least one chemical element selected from zinc (Zn), manganese (Mn), silver (Ag), cobalt (Co), palladium (Pd), nickel (Ni), iron (Fe), copper (Cu) and Ytterbium (Yb); more preferably, the metalled arylazide functionalized-photosensitizer comprises at least one atom of zinc (Zn). According to one embodiment, the arylazide functionalized-photosensitizer is able to produce singlet oxygen and/or reactive oxygen species (ROS). In one embodiment, the arylazide functionalized-photosensitizer under the form of free base, is able to produce singlet oxygen and/or reactive oxygen species (ROS). In one embodiment, the unmetalled arylazide functionalized-photosensitizer is able to produce singlet oxygen and/or reactive oxygen species (ROS). In one embodiment, the metallized arylazide functionalized- photosensitizer is able to produce singlet oxygen and/or reactive oxygen species (ROS).

According to one embodiment, the arylazide functionalized-photosensitizer is selected from tetrapyrrolic compounds such as porphyrins, chlorins, phthalocyanines, benzoporphyrins, bacteriochlorins, chlorophyll derivatives, corroles, texaphyrins, pheophorbides and bacteriopheophorbides; or non tetrapyrrolic compounds such as phenalenones, xanthenes, coumarins, psoralens, antraquinones, curcuminoids, phenothiazines and cyanines.

According to one embodiment, the arylazide functionalized-photosensitizer is selected from tetrapyrrolic compounds such as porphyrins, chlorins, phthalocyanines, benzoporphyrins, bacteriochlorins, chlorophyll derivatives, corroles, texaphyrins, pheophorbides and bacteriopheophorbides; or non tetrapyrrolic compounds such as phenalenones, xanthenes, coumarins, psoralens, antraquinones, curcuminoids, phenothiazines, bodipy and cyanines. According to one embodiment, the arylazide functionalized-photosensitizer is selected from tetrapyrrolic compounds; preferably from cyclic tetrapyrrolic compounds such as porphyrins, chlorins, phthalocyanines, benzoporphyrins, bacteriochlorins, chlorophyll and or a derivative thereof, pheophorbides and bacteriopheophorbides; more preferably prophyrins. According to one embodiment, the arylazide functionalized-photosensitizer is not a phenylthiazine. According to one embodiment, the arylazide functionalized- photosensitizer does not comprise a phenylthiazinyl or phenothiazinyl group. According to one embodiment, the arylazide functionalized-photosensitizer is not an anthraquinone or a derivative thereof. According to one embodiment, the arylazide functionalized- photosensitizer does not comprise an anthraquinonyl group. According to one embodiment, the arylazide functionalized-photosensitizer is not a rhodamine or a derivative thereof. According to one embodiment, the arylazide functionalized- photosensitizer does not comprise a rhodaminyl group. According to one embodiment, the arylazide functionalized-photosensitizer does not comprise alkyne functions. According to one embodiment, the arylazide functionalized-photosensitizer is not a protoporphyrin. According to one embodiment, the arylazide functionalized- photosensitizer is not a metalled protoporphyrin such as a Zinc-metalled protoporphyrin.According to one embodiment, the arylazide functionalized- photosensitizer is selected from tetrapyrrolic compounds such as porphyrins, chlorins, phthalocyanines, benzoporphyrins, bacteriochlorins, chlorophyll derivatives, corroles, texaphyrins, pheophorbides and bacteriopheophorbides; preferably cyclic tetrapyrrolic compounds; or non tetrapyrrolic compounds selected from xanthenes, coumarins, psoralens, antraquinones, curcuminoids and cyanines.

According to one embodiment, the arylazide functionalized-photosensitizer is selected from tetrapyrrolic compounds such as porphyrins, chlorins, phthalocyanines, benzoporphyrins, bacteriochlorins, chlorophyll derivatives, corroles, texaphyrins, pheophorbides and bacteriopheophorbides; preferably cyclic tetrapyrrolic compounds; or non tetrapyrrolic compounds selected from xanthenes, curcuminoids and cyanines.

According to one embodiment, the arylazide functionalized-photosensitizer is selected from tetrapyrrolic compounds such as porphyrins, chlorins, phthalocyanines, benzoporphyrins, bacteriochlorins, chlorophyll derivatives, corroles, texaphyrins, pheophorbides and bacteriopheophorbides; preferably cyclic tetrapyrrolic compounds; or non tetrapyrrolic compounds selected from bodipy, xanthenes, coumarins, psoralens, antraquinones, curcuminoids and cyanines.

According to one embodiment, the arylazide functionalized-photosensitizer is selected from tetrapyrrolic compounds such as porphyrins, chlorins, phthalocyanines, benzoporphyrins, bacteriochlorins, chlorophyll derivatives, corroles, texaphyrins, pheophorbides and bacteriopheophorbides; preferably cyclic tetrapyrrolic compounds; or non tetrapyrrolic compounds selected from bodipy, xanthenes, curcuminoids and cyanines. Advantageously, the arylazide functionalized-photosensitizer of the invention is not altered during its grafting by UV irradiation on the unmodified support. Advantageously, the arylazide functionalized-photosensitizer of the invention is not altered during its grafting by UV irradiation at a wavelength ranging from 300 nm to 380 nm, on the unmodified support. According to one embodiment, the arylazide functionalized-photosensitizer is selected from arylazide porphyrins. According to one embodiment, the arylazide functionalized- photosensitizer is an arylazide functionalized -10,15,20-triphenyl porphyrin. According to one embodiment, the arylazide functionalized-photosensitizer is an arylazide functionalized 10,15,20-triaryl porphyrin. According to one embodiment, the arylazide functionalized-photosensitizer is an arylazide functionalized- 10,15,20-tripyridinium porphyrin. According to one embodiment, the arylazide functionalized-photosensitizer is an arylazide functionalized- 10,15,20-tri(alkylpyridinium) porphyrin. According to one embodiment, the arylazide functionalized-photosensitizer is an arylazide functionalized- 10,15,20-M(N-alkylpyridinium) porphyrin. According to one embodiment, the arylazide functionalized-photosensitizer is an arylazide functionalized-10,15,20-triaryl porphyrin halide. According to one embodiment, the arylazide functionalized-photosensitizer is an arylazide functionalized-10,15,20-tripyridinium porphyrin halide. According to one embodiment, the arylazide functionalized-photosensitizer is an arylazide functionalized- 10,15,20-M(alkylpyri(linium) porphyrin halide.

According to one embodiment, the arylazide functionalized-photosensitizer is a neutral arylazide porphyrin. According to one embodiment, the arylazide functionalized- photosensitizer is 5-(4-azidophenyl)-10,15,20-triphenyl porphyrin (TPP-N3).

According to one embodiment, the arylazide functionalized-photosensitizer is an electronically charged arylazide porphyrin; preferably, a cationic arylazide porphyrin. According to one embodiment, the arylazide functionalized-photosensitizer is 5-(4-azidophenyl)-10,15,20- M-(N-memyl-4-pyriciMum)porphyrin triiodide.

In the present invention, the expression "electronically charged" refers to any compounds being either cationic (lack of electrons, positive Zeta potential) or anionic (excess of electrons, negative Zeta potential). For instance, the Zeta potential of the surface may be measured by an electrokinetic analyzer for solid surface analysis such as SurPASS™ 3 (Anton Paar).

According to one embodiment, the solution of step (i) comprises a solvent selected from polar solvents. According to one embodiment, the solvent is water, preferably milliQ^® water. According to one embodiment, the solvent is selected from organic solvents, preferably from organic polar solvents, more preferably the solvent is a volatile organic polar solvent. In one embodiment, the solvent is acetone.

According to one embodiment, the solution of step (i) comprises water and at least one charged arylazide functionalized-photosensitizer. According to one embodiment, the solution of step (i) comprises water and at least one charged arylazide functionalized- porphyrin. According to one embodiment, the solution of step (i) comprises water and at least one cationic arylazide functionalized-porphyrin. According to one embodiment, the solution of step (i) comprises a polar organic solvent and at least one neutral arylazide functionalized-photosensitizer. According to one embodiment, the solution of step (i) comprises a polar organic solvent and at least one neutral arylazide functionalized-porphyrin. According to one embodiment, the solution of step (i) comprises a polar organic solvent and at least one cationic arylazide functionalized-porphyrin.

According to one embodiment, the concentration of the arylazide functionalized- photosensitizer solution in the solvent ranges from more than 0 to 10 mg/mL; preferably, from 0.01 to 5 mg/mL; more preferably, from 0.1 to 1 mg/mL. According to one embodiment, the concentration of the arylazide functionalized-photosensitizer solution in the solvent ranges from 1 to 10 mg/mL; preferably is about 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10 mg/mL. According to one embodiment, the concentration of the arylazide functionalized-photosensitizer solution in the solvent ranges from 1 to 10 mg/mL; preferably from 1 to 9 mg/mL; from 1 to 8 mg/mL; from 1 to 7 mg/mL; from 1 to 6 mg/mL; from 1 to 5 mg/mL; from 1 to 4 mg/mL; from 1 to 3 mg/mL or from 1 to 2 mg/mL. According to one embodiment, the concentration of the arylazide functionalized-photosensitizer solution in the solvent ranges from 0.1 to 1 mg/mL; preferably from 0.1 to 0.9 mg/mL; from 0.1 to 0.8 mg/mL; from 0.1 to 0.7 mg/mL; from 0.1 to 0.6 mg/mL; from 0.1 to 0.5 mg/mL; from 0.1 to 0.4 mg/mL; from 0.1 to 0.3 mg/mL; or from 0.1 to 0.2 mg/mL.

According to one embodiment, the step (i) is carried out at a temperature ranging from 10°C to 50°C; preferably, the step (i) is carried out at room temperature. According to one embodiment, the step (i) is carried out at a temperature ranging from 10°C to 50°C; preferably from 10°C to 45°C; from 10°C to 40°C; from 10°C to 35°C; from 10°C to 30°C; from 10°C to 25°C; from 10°C to 20°C or from 10°C to 15°C. According to one embodiment, the step (i) is carried out at a temperature of about 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49 or 50°C. According to one embodiment, the step (i) is carried out at a temperature ranging from 15°C to 50°C; preferably from 20°C to 50°C; from 25°C to 50°C; from 30°C to 50°C; from 35°C to 50°C; from 40°C to 50°C; or from 45°C to 50°C.

According to one embodiment, the step (i) is carried out at atmospheric pressure.

According to one embodiment, the solution of step (i) is homogeneous, i.e. the arylazide functionalized-photosensitizer is homogeneously dissolved in the solvent.

In the present invention, "unmodified support" means that the support is not modified before the grafting step in order to introduce chemical functions on the support that are involved in the grafting process. Advantageously, the process of the invention allows to use the support as such. According to one embodiment, the unmodified support may be any support known by the skilled artisan. In one embodiment, the unmodified support may be a hard or a flexible support. According to one embodiment, the terms "unmodified support" mean that the support is not modified before the grafting step in order to introduce hydroxylate functions on the support that are involved in the grafting process. According to one embodiment, the terms "unmodified support" mean that the support is not modified before the grafting step in order to introduce azide functions on the support that are involved in the grafting process. According to one embodiment, the unmodified support does not comprise azide functions. According to one embodiment, the unmodified support is not a cellulosic surface having azide functions. According to one embodiment, the terms "unmodified support" mean that the support is not modified before the grafting step in order to introduce alkyne functions on the support that are involved in the grafting process. According to one embodiment, the unmodified support is not a cellulosic surface having alkyne functions. According to one embodiment, the terms "unmodified support" mean that the support is not modified before the grafting step in order to introduce sulfide functions on the support that are involved in the grafting process. According to one embodiment, the unmodified support is not a cellulosic surface having sulfide functions. According to one embodiment, the unmodified support is not a regenerated cellulosic support. In one embodiment, the unmodified support is selected from support comprising polymer; preferably a polymer selected from the group of polystyrene, polyacrylates, polymethacrylates, polyolefins (such as polyethylene, polypropylene, polybutadiene), polyurethanes, polyacrylonitriles, polyamides, polyesters, polycarbonates, polyethers, polyimides, polyketones, polysiloxanes, polyepoxydes and their copolymers and/or mixtures thereof. In one embodiment, the synthetic support is a support comprising polyethylene.

In one embodiment, the unmodified support is selected from supports made of polymer; preferably a polymer selected from the group of polystyrene, polyacrylates, polymethacrylates, polyolefins (such as polyethylene, polypropylene, polybutadiene), polyurethanes, polyacrylonitriles, polyamides, polyesters, polycarbonates, polyethers, polyimides, polyketones, polysiloxanes, polyepoxydes and their copolymers and/or mixtures thereof. In one embodiment, the synthetic support is a support made of polyethylene. In one embodiment, the synthetic support is polyethylene Tyvek^®. In one embodiment, the unmodified support is not nylon.

In one embodiment, the synthetic support is a thermoplastic polymer. In one embodiment, the synthetic support is an elastomer. In one embodiment, the synthetic support is selected a thermosetting polymer.

In one embodiment, the unmodified support comprises synthetic or natural polymer. In one embodiment, the unmodified support comprises cellulosic polymer. In one embodiment, the unmodified support is made of cellulosic polymer.

In one embodiment, the unmodified support is selected from paper, cotton fabrics or synthetic support; preferably, the unmodified support is cotton fabrics.

According to one embodiment, the unmodified support comprises natural fibers or synthetic fibers. According to one embodiment, the fibers are woven.

According to one embodiment, the step (ii) is carried out at a temperature ranging from 10°C to 50°C; preferably, the step (ii) is carried out at room temperature. According to one embodiment, the step (ii) is carried out at a temperature of about 10, IS, 20, 25, 30, 35, 40, 45 or 50°C.

According to one embodiment, the step (ii) is carried out at a pressure ranging from 220 hPa to 1 200 hPa; preferably, the step (ii) is carried out at atmospheric pressure (i.e. at a pressure of about 1000 hPa). According to one embodiment, the step (ii) is carried out at a pressure ranging from 220 hPa to 1 200 hPa; preferably from 220 hPa to 1 100 hPa; from 220 hPa to 1 000 hPa; from 220 hPa to 900 hPa; from 220 hPa to 800 hPa; from 220 hPa to 700 hPa; from 220 hPa to 600 hPa; from 220 hPa to 500 hPa; from 220 hPa to 400 hPa; or from 220 hPa to 300 hPa. According to one embodiment, the step (ii) is carried out at a pressure ranging from 230 hPa to 1 200 hPa; from 240 hPa to 1 200 hPa; from 250 hPa to 1 200 hPa; from 260 hPa to 1 200 hPa; from 270 hPa to 1 200 hPa; from 280 hPa to 1 200 hPa; from 290 hPa to 1 200 hPa; from 300 hPa to 1 200 hPa; from 310 hPa to 1 200 hPa; from 320 hPa to 1 200 hPa; from 330 hPa to 1 200 hPa; from 340 hPa to 1 200 hPa; from 350 hPa to 1 200 hPa; from 360 hPa to 1 200 hPa; from 370 hPa to 1 200 hPa; from 380 hPa to 1 200 hPa; from 390 hPa to 1 200 hPa; from 400 hPa to 1 200 hPa; from 410 hPa to 1 200 hPa; from 420 hPa to 1 200 hPa; from 430 hPa to 1 200 hPa; from 440 hPa to 1 200 hPa; from 450 hPa to 1 200 hPa; from 460 hPa to 1 200 hPa; from 470 hPa to 1 200 hPa; from 480 hPa to 1 200 hPa; from 490 hPa to 1 200 hPa; from 500 hPa to 1 200 hPa; from 510 hPa to 1 200 hPa; from 520 hPa to 1 200 hPa; from 530 hPa to 1 200 hPa; from 540 hPa to 1 200 hPa; from 550 hPa to 1 200 hPa; from 560 hPa to 1 200 hPa; from 570 hPa to 1 200 hPa; from 580 hPa to 1 200 hPa; from 590 hPa to 1 200 hPa; from 600 hPa to 1 200 hPa; from 610 hPa to 1 200 hPa; from 620 hPa to 1 200 hPa; from 630 hPa to 1 200 hPa; from 640 hPa to 1 200 hPa; from 650 hPa to 1 200 hPa; from 660 hPa to 1 200 hPa; from 670 hPa to 1 200 hPa; from 680 hPa to 1 200 hPa; from 690 hPa to 1 200 hPa; from 700 hPa to 1 200 hPa; 710 hPa to 1 200 hPa; from 720 hPa to 1 200 hPa; from 730 hPa to 1 200 hPa; from 740 hPa to 1 200 hPa; from 750 hPa to 1 200 hPa; from 760 hPa to 1 200 hPa; from 770 hPa to 1 200 hPa; from 780 hPa to 1 200 hPa; from 790 hPa to 1 200 hPa; from 800 hPa to 1 200 hPa; 810 hPa to 1 200 hPa; from 820 hPa to 1 200 hPa; from 830 hPa to 1 200 hPa; from 840 hPa to 1 200 hPa; from 850 hPa to 1 200 hPa; from 860 hPa to 1 200 hPa; from 870 hPa to 1 200 hPa; from 880 hPa to 1 200 hPa; from 890 hPa to 1 200 hPa; from 900 hPa to 1 200 hPa; 910 hPa to 1 200 hPa; from 920 hPa to 1 200 hPa; from 930 hPa to 1 200 hPa; from 940 hPa to 1 200 hPa; from 950 hPa to 1 200 hPa; from 960 hPa to 1 200 hPa; from 970 hPa to 1 200 hPa; from 980 hPa to 1 200 hPa; from 990 hPa to 1 200 hPa; from 1000 hPa to 1 200 hPa; 1 010 hPa to 1 200 hPa; from 1 020 hPa to 1 200 hPa; from 1 030 hPa to 1 200 hPa; from 1 040 hPa to 1 200 hPa; from 1 050 hPa to 1 200 hPa; from 1 060 hPa to 1 200 hPa; from 1 070 hPa to 1 200 hPa; from 1 080 hPa to 1 200 hPa; from 1 090 hPa to 1 200 hPa; 1 100 hPa to 1 200 hPa; 1 110 hPa to 1 200 hPa; from 1 120 hPa to 1 200 hPa; from 1 130 hPa to 1 200 hPa; from 1 140 hPa to 1 200 hPa; from 1 150 hPa to 1 200 hPa; from 1 160 hPa to 1 200 hPa; from 1 170 hPa to 1 200 hPa; from 1 180 hPa to 1 200 hPa; or from 1 190 hPa to 1 200 hPa.

According to one embodiment, the solution of step (i) is applying on the unmodified support. In the present invention, the solution of step (i) may be applied on the unmodified support by one of the methods well-known by the skilled artisan such as printing, inkjet printing, screen printing, airbrushing, spraying or soaking. According to one embodiment, the unmodified support is soaked in the solution of step (i). According to one embodiment, the solution of step (i) is sprayed on the unmodified support.

According to one embodiment, the step (ii) further comprises a drying step. According to one embodiment, the step (ii) further comprises a drying step after the step (ii) has been carried out. According to one embodiment, the step (ii) further comprises a step for evaporating the solvent. According to one embodiment, the solvent is totally evaporated. According to one embodiment, the solvent is totally evaporated before the grafting step.

According to one embodiment, the step (ii) is carried out in a dark environment, i.e. in an environment protected from light. According to one embodiment, the step (iii) is carried out at a temperature ranging from 10°C to 300°C; preferably, from 200°C to 250°C. According to one embodiment, the step (iii) is carried out at a temperature ranging from 10°C to 300°C; preferably from 20°C to 300°C; 30°C to 300°C; 40°C to 300°C; 50°C to 300°C; 60°C to 300°C; 70°C to 300°C; 80°C to 300°C; 90°C to 300°C; 100°C to 300°C; 110°C to 300°C; 120°C to 300°C; 130°C to 300°C; 140°C to 300°C; 150°C to 300°C; 160°C to 300°C; 170°C to 300°C; 180°C to 300°C; 190°C to 300°C; 200°C to 300°C; 210°C to 300°C; 220°C to 300°C; 230°C to 300°C; 240°C to 300°C; 250°C to 300°C; 260°C to 300°C; 270°C to 300°C; or 290°C to 300°C. According to one embodiment, the step (iii) is carried out at a temperature ranging from 10°C to 290°C; from 10°C to 280°C; from 10°C to 270°C; from 10°C to 260°C; from 10°C to 250°C; from 10°C to 240°C; from 10°C to 230°C; from 10°C to 220°C; from 10°C to 210°C; from 10°C to 200°C; from 10°C to 190°C; from 10°C to 180°C; from 10°C to 170°C; from 10°C to 160°C; from 10°C to 150°C; from 10°C to 140°C; from 10°C to 130°C; from 10°C to 120°C; from 10°C to 110°C; from 10°C to 100°C; from 10°C to 90°C; from 10°C to 80°C; from 10°C to 70°C; from 10°C to 60°C; from 10°C to 50°C; from 10°C to 40°C; from 10°C to 30°C or from 10°C to 20°C. According to one embodiment, the step (iii) is carried out at a temperature of about 10, IS, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 100, 105, 110, 115, 120, 125, 130, 135, 140, 145,150,155, 160, 165, 170, 175, 180, 185, 190, 195 or 200. According to one embodiment, the step (iii) is carried out at a pressure ranging from 220 hPa to 1 200 hPa; preferably, the step (iii) is carried out at atmospheric pressure (i.e. at a pressure of about 1000 hPa). According to one embodiment, the step (iii) is carried out at a pressure ranging from 220 hPa to 1 200 hPa; preferably from 220 hPa to 1 100 hPa; from 220 hPa to 1 000 hPa; from 220 hPa to 900 hPa; from 220 hPa to 800 hPa; from 220 hPa to 700 hPa; from 220 hPa to 600 hPa; from 220 hPa to 500 hPa; from 220 hPa to 400 hPa; or from 220 hPa to 300 hPa. According to one embodiment, the step (iii) is carried out at a pressure ranging from 230 hPa to 1 200 hPa; from 240 hPa to 1 200 hPa; from 250 hPa to 1 200 hPa; from 260 hPa to 1 200 hPa; from 270 hPa to 1 200 hPa; from 280 hPa to 1 200 hPa; from 290 hPa to 1 200 hPa; from 300 hPa to 1 200 hPa; from 310 hPa to 1 200 hPa; from 320 hPa to 1 200 hPa; from 330 hPa to 1 200 hPa; from 340 hPa to 1 200 hPa; from 350 hPa to 1 200 hPa; from 360 hPa to 1 200 hPa; from 370 hPa to 1 200 hPa; from 380 hPa to 1 200 hPa; from 390 hPa to 1 200 hPa; from 400 hPa to 1 200 hPa; from 410 hPa to 1 200 hPa; from 420 hPa to 1 200 hPa; from 430 hPa to 1 200 hPa; from 440 hPa to 1 200 hPa; from 450 hPa to 1 200 hPa; from 460 hPa to 1 200 hPa; from 470 hPa to 1 200 hPa; from 480 hPa to 1 200 hPa; from 490 hPa to 1 200 hPa; from 500 hPa to 1 200 hPa; from 510 hPa to 1 200 hPa; from 520 hPa to 1 200 hPa; from 530 hPa to 1 200 hPa; from 540 hPa to 1 200 hPa; from 550 hPa to 1 200 hPa; from 560 hPa to 1 200 hPa; from 570 hPa to 1 200 hPa; from 580 hPa to 1 200 hPa; from 590 hPa to 1 200 hPa; from 600 hPa to 1 200 hPa; from 610 hPa to 1 200 hPa; from 620 hPa to 1 200 hPa; from 630 hPa to 1 200 hPa; from 640 hPa to 1 200 hPa; from 650 hPa to 1 200 hPa; from 660 hPa to 1 200 hPa; from 670 hPa to 1 200 hPa; from 680 hPa to 1 200 hPa; from 690 hPa to 1 200 hPa; from 700 hPa to 1 200 hPa; 710 hPa to 1 200 hPa; from 720 hPa to 1 200 hPa; from 730 hPa to 1 200 hPa; from 740 hPa to 1 200 hPa; from 750 hPa to 1 200 hPa; from 760 hPa to 1 200 hPa; from 770 hPa to 1 200 hPa; from 780 hPa to 1 200 hPa; from 790 hPa to 1 200 hPa; from 800 hPa to 1 200 hPa; 810 hPa to 1 200 hPa; from 820 hPa to 1 200 hPa; from 830 hPa to 1 200 hPa; from 840 hPa to 1 200 hPa; from 850 hPa to 1 200 hPa; from 860 hPa to 1 200 hPa; from 870 hPa to 1 200 hPa; from 880 hPa to 1 200 hPa; from 890 hPa to 1 200 hPa; from 900 hPa to 1 200 hPa; 910 hPa to 1 200 hPa; from 920 hPa to 1 200 hPa; from 930 hPa to 1 200 hPa; from 940 hPa to 1 200 hPa; from 950 hPa to 1 200 hPa; from 960 hPa to 1 200 hPa; from 970 hPa to 1 200 hPa; from 980 hPa to 1 200 hPa; from 990 hPa to 1 200 hPa; from 1000 hPa to 1 200 hPa; 1 010 hPa to 1 200 hPa; from 1 020 hPa to 1 200 hPa; from 1 030 hPa to 1 200 hPa; from 1 040 hPa to 1 200 hPa; from 1 050 hPa to 1 200 hPa; from 1 060 hPa to 1 200 hPa; from 1 070 hPa to 1 200 hPa; from 1 080 hPa to 1 200 hPa; from 1 090 hPa to 1 200 hPa; 1 100 hPa to 1 200 hPa; 1 110 hPa to 1 200 hPa; from 1 120 hPa to 1 200 hPa; from 1 130 hPa to 1 200 hPa; from 1 140 hPa to 1 200 hPa; from 1 150 hPa to 1 200 hPa; from 1 160 hPa to 1 200 hPa; from 1 170 hPa to 1 200 hPa; from 1 180 hPa to 1 200 hPa; or from 1 190 hPa to l 200 hPa.

In the present invention, the arylazide functionalized-photosensitizer is covalently grafted by an insertion reaction, to the support. By "insertion reaction", it means a chemical reaction that lead to the insertion of the compound to be grafted into a single C-H bond and/or N-H bond of the support. Especially, in the present invention, phenyl azide functions are used for allowing implementing the insertion reaction by stabilizing nitrene intermediates contrary to aliphatic azide compounds. The activation of the phenyl azide functions lead to nitrene intermediates able to be inserted in a R-H closest bond (R may be C, N or O atom) of the support to restore its valence. Contrary to click chemistry reaction, the insertion reaction does not requires neither the pre-functionalization of the reagents by suitable functions, nor the use of catalyst (copper for example) for carrying out the click reaction. Especially, when a click chemistry is carried out from an azide functionaiized compound, the other reagent has to carry an alkyne function. In the insertion reaction of the present invention, the unmodified support is not required to carry out an alkyne function.

The process of the invention does not comprises any click chemistry reaction; especially, the process of the invention does not comprise any cycloaddition step such as 1,3-dipolar cycloaddition. According to one embodiment, the insertion reaction is initiated by a thermal activation or a UV irradiation activation of the arylazide function of the photosensitizer. According to one embodiment, the thermal activation or UV irradiation activation may be carried out by any well-known method of the skilled artisan. Especially, the skilled artisan would be able to adapt the activation time depending on the power of the used apparatus. For example, the thermal activation may be carried out, but not limited to, the use of an oven, an infrared lamp or a thermal dryer. According to one embodiment, the thermal activation is carried out at a temperature ranging from 100°C to 300°C; more preferably, ranging from 200°C to 250°C. According to one embodiment, the thermal activation is carried out at a temperature ranging from 100°C to 300°C; preferably from 110°C to 300°C; 120°C to 300°C; 130°C to 300°C; 140°C to 300°C; 150°C to 300°C; 160°C to 300°C; 170°C to 300°C; 180°C to 300°C; 190°C to 300°C; 200°C to 300°C; 210°C to 300°C; 220°C to 300°C; 230°C to 300°C; 240°C to 300°C; 250°C to 300°C; 260°C to 300°C; 270°C to 300°C; or 290°C to 300°C. According to one embodiment, the thermal activation is carried out at a temperature ranging from 100°C to 290°C; from 100°C to 280°C; from 100°C to 270°C; from 100°C to 260°C; from 100°C to 250°C; from 100°C to 240°C; from 100°C to 230°C; from 100°C to 220°C; from 100°C to 210°C; from 100°C to 200°C; from 100°C to 190°C; from 100°C to 180°C; from 100°C to 170°C; from 100°C to 160°C; from 100°C to 150°C; from 100°C to 140°C; from 100°C to 130°C; from 100°C to 120°C; or from 100°C to 110°C. According to one embodiment, the thermal activation is carried out at a temperature of about 100, 105, 110, 115, 120, 125, 130, 135, 140, 145,150,155, 160, 165, 170, 175, 180, 185, 190, 195 or 200°C.

According to one embodiment, the thermal activation is carried out during a time period ranging from 10s to lh; preferably, from 20s to 30 mn; more preferably, from 30s to 5 mn. According to one embodiment, the thermal activation is carried out during a time period ranging from 1 mn to 10 mn. According to one embodiment, the thermal activation is carried out during a time period ranging from 10s to 3600s; preferably from 50s to 3600s; from 100s to 3600s; from 150s to 3600s; from 200s to 3600s; from 250s to 3600s; from 300s to 3600s; from 350s to 3600s; from 400s to 3600s; from 450s to 3600s; from 500s to 3600s; from 550s to 3600s; from 600s to 3600s; from 650s to 3600s; from 700s to 3600s; from 750s to 3600s; from 800s to 3600s; from 850s to 3600s; from 900s to 3600s; from 950s to 3600s; from 1000s to 3600s; from 1050s to 3600s; from 1100s to 3600s; from 1150s to 3600s; from 1200s to 3600s; from 1250s to 3600s; from 1300s to 3600s; from 1350s to 3600s; from 1400s to 3600s; from 1450s to 3600s; from 1500s to 3600s; from 1550s to 3600s; from 1600s to 3600s; from 1650s to 3600s; from 1700s to 3600s; from 1750s to 3600s; from 1800s to 3600s; from 1850s to 3600s; from 1900s to 3600s; from 1950s to 3600s; from 2000s to 3600s; from 2050s to 3600s; from 2100s to 3600s; from 2150s to 3600s; from 2200s to 3600s; from 2250s to 3600s; from 2300s to 3600s; from 2350s to 3600s; from 2400s to 3600s; from 2450s to 3600s; from 2500s to 3600s; from 2550s to 3600s; from 2600s to 3600s; from 2650s to 3600s; from 2700s to 3600s; from 2750s to 3600s; from 2800s to 3600s; from 2850s to 3600s; from 2900s to 3600s; from 3000s to 3600s; from 3050s to 3600s; from 3100s to 3600s; from 3150s to 3600s;

from 3200s to 3600s; from 3250s to 3600s; from 3300s to 3600s; from 3350s to 3600s; from 3400s to 3600s; from 3450s to 3600s; from 3500s to 3600s; or from 3550s to 3600s.

According to one embodiment, the UV irradiation activation is not carried out by a low pressure UV lamp. According to one embodiment, the UV irradiation activation is not carried out by a mercury lamp. According to one embodiment, the UV irradiation activation is not carried out by a high-pressure mercury lamp.

According to one embodiment, the UV irradiation activation is carried out at a wavelength which is not selected from absorption wavelengths of the photosensitizer for its activation. According to one embodiment, the UV irradiation activation is carried out at a wavelength which is not selected from absorption wavelengths of porphyrin for its activation. According to one embodiment, the UV irradiation activation is carried out at a wavelength which is not selected from absorption wavelengths of arylazide porphyrin for its activation.

According to one embodiment, the UV irradiation activation is carried out at a wavelength ranging from 10 nm to 400 nm; preferably, from 200 nm to 370 nm; preferably, from 300 nm to 380 nm; more preferably, the wavelength is about 365 nm. According to one embodiment, the UV irradiation activation is carried out at a wavelength higher than 300 nm, preferably ranging from 300 nm to 400 nm, preferably from 300 nm to 380 nm, more preferably the wavelength is about 365 nm. According to one embodiment, the UV irradiation activation is not carried out at a wavelength lower than 300 nm. According to one embodiment, the UV irradiation activation is not carried out at a wavelength of about 254 nm. According to one embodiment, the UV irradiation activation is not carried out at a wavelength of about 250 nm.

According to one embodiment, the UV irradiation activation is carried out during a time period ranging from 1 min to 24h. According to one embodiment, the UV irradiation activation is carried out during a time period ranging from 30 mn to lOh. According to one embodiment, the UV irradiation activation is carried out 24h. According to one embodiment, the UV irradiation activation is carried out 4h. According to one embodiment, the UV irradiation activation is carried out 3h. According to one embodiment, the UV irradiation activation is carried out 2h. According to one embodiment, the UV irradiation activation is carried out lh. According to one embodiment, the UV irradiation activation is carried out 45 min. According to one embodiment, the UV irradiation activation is carried out 30 min. According to one embodiment, the UV irradiation activation is carried out 20 min. According to one embodiment, the UV irradiation activation is carried out 10 min. According to one embodiment, the UV irradiation activation is carried out during a time period of about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23 or 24h. Advantageously, the process of the invention allows implementing the grafting of the photosensitizer by irradiation on the unmodified support without altering the properties of photosensitizer. In one embodiment, the grafted porphyrin keeps good biocide and/or bactericidal properties after being grafted on an unmodified support. Advantageously, the process of the invention allows providing materials becoming biocide and/or bactericidal materials when placed under the light; preferably, when placed under natural light (i.e. sunlight). Especially, in the present invention, bacteria are killed due to the activation by irradiation of the porphyrins.

The process of the invention as defined above, may further comprise a step for activating biocide and/or bactericidal properties of the photosensibilizer. Especially, the present invention also relates to a process for manufacturing a biocide and/or bactericidal material comprising:

(i) preparing a solution comprising at least one arylazide functionalized- photosensitizer,

(ii) contacting the solution of step (i) and a unmodified support thereby resulting in depositing the arylazide functionalized-photosensitizer on the support;

(iii) covalently grafting by an insertion reaction, the arylazide functionalized- photosensitizer deposited on the support at step (ii) thereby resulting in a biocide and/or bactericidal material, said insertion reaction being carried out by a thermal activation and/or a UV irradiation activation; and

(iv) carrying out the activation of the biocide and/or bactericidal properties of the material at step (iii).

According to one embodiment, the activation of the biocide and/or bactericidal properties of the material of the invention is carried out by UV irradiation. According to one embodiment, the UV irradiation of the biocide and/or bactericidal material may be carried out by any method well-known by the skilled artisan. Especially, the UV irradiation time for activating the biocide and/or bactericidal properties of the material depends on the nature of organisms and of the power of the used lamp. According to one embodiment, the biocide and/or bactericidal properties of the material of the invention are activated after an irradiation time ranging from more than 0 min to less than 24h. According to one embodiment, the biocide and/or bactericidal properties of the material of the invention are activated after an irradiation time ranging from lh to less than 24h, preferably 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23 or 24h. According to one embodiment, the biocide and/or bactericidal properties of the material of the invention are activated after an irradiation time ranging from lmin to 60 min, preferably 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, or 60 min.

According to one embodiment, the biocide and/or bactericidal properties of the material of the invention are activated after an irradiation at a wavelength ranging from 400 nm to 750 nm. According to one embodiment, the biocide and/or bactericidal properties of the material of the invention are activated after an irradiation at a wavelength ranging from 400 nm to 700 nm; preferably from 400 nm to 650 nm; from 400 nm to 600 nm; from 400 nm to 550 nm; or from 400 nm to 500 nm. According to one embodiment, the biocide and/or bactericidal properties of the material of the invention are activated after an irradiation at a wavelength ranging from 400 nm to 700 nm; preferably from 450 nm to 700 nm; from 500 nm to 700 nm; from 550 nm to 700 nm; from 600 nm to 700 nm; or from 650 nm to 700 nm.

This invention also relates to a biocide and/or bactericidal material comprising or consisting of:

(a) a unmodified support; and

(b) at least one arylazide-functionalized photosensitizer,

According to one embodiment, the biocide and/or bactericidal material comprises or consists of:

(a) a support, preferably a raw support; and

(b) at least one arylazide-functionalized photosensitizer, said arylazide-functionalized photosensitizer being covalently grafted to the support through an insertion bond.

According to one embodiment, the biocide and/or bactericidal material results from a raw support as defined above, which has been modified by grafting at least one arylazide- functionalized photosensitizer as defined above; said arylazide-functionalized photosensitizer being covalently grafted to the support through an insertion bond.

According to one embodiment, the biocide and/or bactericidal material may be obtained by the process of the invention as described above.

According to one embodiment, the unmodified support is selected from any support that is not modified before the grafting step in order to introduce chemical functions on the support that are involved in the grafting process.

According to one embodiment, the unmodified support is selected from support comprising polymer, preferably a polymer selected from the group of polystyrene, polyacrylates, polymethacrylates, polyolefins (such as polyethylene, polypropylene, polybutadiene), polyurethanes, polyacrylonitriles, polyamides, polyesters, polycarbonates, polyethers, polyimides, polyketones, polysiloxanes, polyepoxydes and their copolymers and/or mixtures thereof. In one embodiment, the synthetic support is a support comprising polyethylene.

In one embodiment, the unmodified support is selected from supports made of polymer; preferably a polymer selected from the group of polystyrene, polyacrylates, polymethacrylates, polyolefins (such as polyethylene, polypropylene, polybutadiene), polyurethanes, polyacrylonitriles, polyamides, polyesters, polycarbonates, polyethers, polyimides, polyketones, polysiloxanes, polyepoxydes and their copolymers and/or mixtures thereof. In one embodiment, the synthetic support is a support made of polyethylene. In one embodiment, the synthetic support is polyethylene Tyvek^®.

In one embodiment, the synthetic support is a thermoplastic polymer. In one embodiment, the synthetic support is an elastomer. In one embodiment, the synthetic support is selected a thermosetting polymer. In one embodiment, the unmodified support comprises synthetic or natural polymer. In one embodiment, the unmodified support comprises cellulosic polymer. In one embodiment, the unmodified support is made of cellulosic polymer.

According to one embodiment, the arylazide functionalized-photosensitizer is selected from the group of arylazide functionalized-photosensitizer in which the photosensitizer is under the form of free base.

According to one embodiment, the arylazide functionalized-photosensitizer is selected from the group of unmetalled arylazide functionalized-photosensitizer.

According to one preferred embodiment, the metalled arylazide functionalized- photosensitizer comprises a metal which does not prevent the production of singlet oxygen and/or reactive oxygen species (ROS) by the photosensitizer of the invention. In one embodiment, the arylazide functionalized-photosensitizer comprises at least one chemical element selected from zinc (Zn), manganese (Mn), silver (Ag), cobalt (Co), palladium (Pd), nickel (Ni), iron (Fe), copper (Cu) and Ytterbium (Yb); more preferably, the metalled arylazide functionalized-photosensitizer comprises at least one atom of zinc (Zn). In one embodiment, the arylazide functionalized-photosensitizer comprises at least one chemical element selected from manganese (Mn), silver (Ag), cobalt (Co), palladium (Pd), nickel (Ni), iron (Fe), copper (Cu) and Ytterbium (Yb). According to one preferred embodiment, the metalled arylazide functionalized-photosensitizer does not comprise zinc (Zn). According to one embodiment, the arylazide functionalized-photosensitizer is able to produce singlet oxygen and/or reactive oxygen species (ROS). In one embodiment, the arylazide functionalized-photosensitizer under the form of free base, is able to produce singlet oxygen and/or reactive oxygen species (ROS). In one embodiment, the unmetalled arylazide functionalized-photosensitizer is able to produce singlet oxygen and/or reactive oxygen species (ROS). In one embodiment, the metallized arylazide functionalized- photosensitizer is able to produce singlet oxygen and/or reactive oxygen species (ROS).

According to one embodiment, the arylazide functionalized-photosensitizer is selected from tetrapyrrolic compounds such as porphyrins, chlorins, phthalocyanines, benzoporphyrins, bacteriochlorins, chlorophyll derivatives, corroles, texaphyrins, pheophorbides and bacteriopheophorbides; or non tetrapyrrolic compounds such as phenalenones, xanthenes, coumarins, psoralens, antraquinones, curcuminoids, phenothiazines and cyanines. According to one embodiment, the arylazide functionalized-photosensitizer is not a phenothiazine. According to one embodiment, the arylazide functionalized-photosensitizer is not an antraquinone.

According to one embodiment, the arylazide functionalized-photosensitizer is selected from arylazide porphyrins. According to one embodiment, the arylazide functionalized- photosensitizer is an arylazide functionalized -10,15,20-triphenyl porphyrin. According to one embodiment, the arylazide functionalized-photosensitizer is an arylazide functionalized 10,15,20-triaryl porphyrin. According to one embodiment, the arylazide functionalized-photosensitizer is an arylazide functionalized- 10,15, 20-tripyridinium porphyrin. According to one embodiment, the arylazide functionalized-photosensitizer is an arylazide functionalized- 10,15,20-tri(alkylpyridinium) porphyrin. According to one embodiment, the arylazide functionalized-photosensitizer is an arylazide functionalized- 10,15,20-M(N-alkylpyri(linium) porphyrin. According to one embodiment, the arylazide functionalized-photosensitizer is an arylazide functionalized-10,15,20-triaryl porphyrin halide. According to one embodiment, the arylazide functionalized-photosensitizer is an arylazide functionalized-10,15,20-tripyridinium porphyrin halide. According to one embodiment, the arylazide functionalized-photosensitizer is an arylazide functionalized- 10,15,20-M(alkylpyridinium) porphyrin halide.

According to one embodiment, the arylazide functionalized-photosensitizer is a neutral arylazide porphyrin. According to one embodiment, the arylazide functionalized- photosensitizer is 5-(4-azidophenyl)-10,15,20-triphenyl porphyrin (TPP-N3). According to one embodiment, the arylazide functionalized-photosensitizer is an electronically charged arylazide porphyrin; preferably, a cationic arylazide porphyrin. According to one embodiment, the arylazide functionalized-photosensitizer is 5-(4-azidophenyl)-10,15,20- M-(N-memyl-4-pyriclMum)porphyrin triiodide.

In the present invention, the amount of the arylazide functionalized-photosensitizer grafted on the unmodified support is determined by UV- visible titration. According to one embodiment, the arylazide functionalized-photosensitizer is grafted on the unmodified support as defined above in a range from more than 0 to 1 μπιοΐ/ mg of said support; preferably from 0.001 to 0.04 μιηοΐ/mg. According to one embodiment, the amount of the arylazide functionalized-photosensitizer grafted on the unmodified support, is about 0.008 μιηοΐ/mg of support. According to one embodiment, the amount of the arylazide functionalized-photosensitizer grafted on the unmodified support, is about 0.025 μmol/mg of support.

This invention also relates to the use of the biocide and/or bactericidal material as defined above. According to one embodiment, the material of the invention is useful in the preparation of clothes or coatings; preferably, in the preparation of protective clothes or protective coatings. According to one embodiment, the material of the invention is useful in the decontamination of water and/or biological fluids.

According to one embodiment, the material of the invention is useful in the decontamination of biological surfaces. The present invention also relates to a kit comprising:

— in a first compartment, an unmodified support as defined above, preferably selected from paper, cotton fabrics or synthetic support; and

— in a second compartment, a solution of at least one arylazide-functionalized photosensitizer as defined above. According to one embodiment, the kit of the invention allows keeping the solution of at least one arylazide-functionalized photosensitizer, protected from light.

BRIEF DESCRIPTION OF THE DRAWINGS

Figure 1 is spectra showing the presence of Soret bands that corresponds to the high absorbing zone of porphyrin compounds in the blue- violet visible wavelength for arylazide-functionalized porphyrins grafted to cotton fabrics (spectrum 1), piece of polyethylene cloth (spectrum 2) and Whatman paper (spectrum 3).

EXAMPLES

The present invention is further illustrated by the following examples. Abbreviations

CHCl₃: chloroform (or trichloromethane);

DMF: dimethylformamide;

ε: molar extinction coefficient;

Equiv.: equivalent;

h: hour(s);

L: liter,

M: mol/L; min: minute;

mg: milligram(s);

mL: milliliter(s);

mmol: millimol(s);

NaOH: sodium hydroxide;

PBS: Phosphate Buffered Saline;

Rn frontal rapport migration.

Materials and Methods

All solvents and reagents were purchased from chemical companies Pyrrole was distilled over CaH2 _under reduced pressure immediately before use. Analytical thin layer chromatography (TLC) was performed on silica gel Merck 60 F254. Merck precoated plates (silica gel 60, 2 mm) were used for preparative thin layer chromatography. Column chromatography was carried out with silica gel columns (60 ACC; 15 - 20 μπι, Merck).

Nuclear Magnetic Resonance (NMR) *H NMR were recorded on Bruker DPX-400 MHz spectrometer at 400.13 MHz. CDCb or DMSO-tfc are used as solvent with tetramethylsilane as an internal standard. The chemical shifts are given in ppm and coupling constant in Hz.

Mass Spectroscopy (MS)

Mass analysis were performed by either using a Matrix-Assisted Laser Desoprtion Ionization MALDI mass spectrometry (MALDI-TOF/TOF, Smart Beam from Bruker).

Fourier Transform Infrared spectroscopy (FTIR)

A Perkin-Elmer 1000 FTIR spectrometer equipped with a spectrum software was used to perform FTIR analysis. The spectra were obtained by preparing KBr powder pellets containing 5% w/w of the investigated sample. UV-Visible spectroscopy (UV-Vis)

UV-Vis spectra were recorded using a Specord 210 (Analytikjena) spectrophotometer using 10-mm quartz cells. Spectra were realized at adequate concentration (ΙΟ^' θ^"6 M) with spectro-grade solvents. Diffuse reflectance UV-Vis spectroscopy (DRW)

DRUV spectra of porphyrin-modified samples were obtained with a CARY 5000 Varian spectrometer using a 110 mm PTFE integrating sphere. Reflectance spectra were recorded against Teflon standard reflectance spectrum. Each spectrum was recorded in the range 350-750 nm. PARTI - CHEMISTRY

Example 1: Synthesis of neutral arvlazide porphyrins

1.1. Synthesis of 5-(4-nitrophenyl)-10.15.20-triphenyl porphyrin (Compound 1)

In a two necked flask, are introduced 302 mg (2 mmol; 1 equiv.) of nitrobenzaldehyde, 0.613 mL (6 mmol; 3 equiv.) of benzaldehyde and 60 mL of propionic acid. After lh heating at about 120°C-130°C under reflux, pyrrole (0.555 mL; 8 mmol; 4 equiv.) previously distilled, is dropped into the reactional mixture. The reaction is carried out lh at about 120°C, under agitation and in the dark. After cooling the mixture at room temperature, the solvent is evaporated in order to provide the crude product. The compound 1 is obtained after a purification step by preparative plates chromatography (CHCb/petrol ethen 6/4). The final product is a purple solid and the yield is about 7.2% (96 mg).

Characterizations

Rf =0.62 (CHCl₃/petrol ether: 6/4).

UV-Visible: CHCb, in nm, (ε, L.cm^.mol ¹ x 10³): 420 (241); 516 (12.2); 552 (7.1); 591 (4.4); 647 (3.1).

MS (MALDI): m/z=660.07 [M+H]⁺.

1.2. Synthesis of 5-(4-aminophenyl)-10.15.20-triphenvl porphyrin (Compound 2)

In a two necked flask, 80 mg (0.121 mmol; 1 equiv.) of compound 1 is solubilized in 20 mL of CHCb. A solution of 82 mg (0.363 mmol; 3 equiv.) of tin chloride in 20 mL of HQ solution (37%) is added followed by 20 mL of acetic acid. Then, the reaction is carried out overnight at about 70°C-80°C, under agitation and in the dark. After cooling at room temperature, the mixture is neutralized with 150 mL of NaOH solution (2M). The crude product is purified by an organic phase extraction followed by washings with ultra- pure water. The final product, compound 2, is a purple solid obtained with a yield of about 80% (61 mg). Characterizations

1.3. Synthesis of 5-(4-azidophenyl)-10.15.20-triphenyl porphyrin TPP-N3 (Compound 3) A solution of 8 mg sodium nitrite (0.141 mmol; 1 equiv. dissolved in 4.5 mL of water), is added to a solution of compound 2 (89 mg; 0.141 mmol; 1 equiv. dissolved in 3 mL of HQ 20%) at a temperature of about 0°C.The mixture is stirred 30 mn in the dark. Then, is added an aqueous solution of sodium nitrite (20 mg; 0.283 mmol; dissolved in 4.5 mL of water). The reactional mixture is stirred lh at room temperature in the dark. After that, the mixture is neutralized at 0°C with NaOH solution (10%) until achieving a pH of about 8. The crude product is purified by an extraction of the aqueous phase with CH2CI2 followed by preparative plates chromatography on silica gel (CHCb/Petroleum ether; 7/3 (v/v)). The final product, compound 3, is a purple solid obtained with a yield of about 91%.

Characterizations

Example 2: Synthesis of charged arvlazide porphyrins 2.1. Synthesis of 5-(4-acetamidophenyl)-10J5.20-M-(4-pyridyl)porphyrin (Compound 4)

4-acetamidobenzaldehyde (11.6 g; 0.043 mol) and 4-pyridinecarboxybenzaldehyde (7.05 g; 0.108 mol) are carried out at reflux in propionic acid (500 mL). First, pyrrole is dropped in the reactional mixture during 2h. Second, the mixture is further stirred at reflux for lh30. Then, the mixture is cooled at room temperature overnight. Propionic acid is removed and trimethylamine is added in the mixture. A purification by chromatography through silica column is carried out via Florisil^® (Silica gel 60; 0.015-0.040 mm, 50 cm x 45 cm). Eluent: CHCb/MeOH; 97:3; CHCb/MeOH; 96:4; CHCb/MeOH; 95:5. Fractions comprising the final product are collected and concentrated under reduced pressure. A pure fraction, compound 4, (492.5 mg; 7.30.10-4 mol; 2%) is obtained. 2.2. Synthesis of 5-(4-ammophenyl)-10,15 ,20-TRI-(4-pyridyl)porphyrm (Compound 5)

Compound 4 (205.7 mg; 0.310 mmol) is solubilized in 200 mL of a HC1 solution (5N). The mixture is heated at 80°C during 3 hours then concentrated under reduced pressure and neutralized with NaOH solution (6M). The crude product is removed by an extraction with CH2CI2. After a drying step with MgS0₄, the final product is removed by a precipitation step in methanol. A pure fraction, compound 5, (492.9 mg; 7.30.10-⁴ mol; 2%) is obtained.

2.3. Synthesis of 5-(4-azidophenvl)-10.15.20- tri-(4-pvridvl)porphvrin (Compound 6)

Compound 5 (32 mg; 0.051 mmol) is solubilized at about 0°C in 0.5 mL of trifluoroacetic acid (TFA). This solution is dropped into a sodium nitrite solution (6.98 mg; 0.101 mmol, in 0.07 mL of water). The mixture is stirred at 0°C for 15 min followed by the dropped addition of azide sodium solution (13.2 mg; 0.202 mmol, dissolved in 0.07 mL of water). The mixture is stirred lh at 0°C and then diluted with water. A saturated solution of sodium hydrogen carbonate is added to the mixture until that the color of the solution changes from green to purple. The crude product is removed by an extraction with CHCb.The organic phase is dried with MgS0₄ and concentrated under reduced pressure. A purification by chromatography through silica column is carried out via Florisil^® (Silica gel 60; 0.015-0.040 mm, 50 cm x 45 cm). Eluent: CHCl₃/MeOH; 97:3. Fractions comprising the final product are collected and concentrated under reduced pressure. After a recrystallization, the compound 6 is obtained (31.9 mg; 95%). 2.4. Synthesis of 5-(4-azidophenvl)-10.15.20- tri-(N-memvl-4-pvriclinium)porphvrin triiodide (Compound 7)

Iodomethane (0.9 mL; 14.46 mmol; 213 equiv.) is added into a solution of compound 6 (45.1 mg; 0.068 mmol; 1 equiv., dissolved in 4.5 mL of anhydrous DMF). The reactional mixture is stirred during 24h at 40°C. The product is then removed by a precipitation step in cold diethyl ether and then, washed many times with cold diethyl ether. The pure product, compound 7, is obtained with a yield of about 88% (65.2 mg, purple solid).

Example 3: Insertion reaction 3.1. from neutral arylazide porphyrin (compound 3)

The compound 3 was dissolved in acetone (0.1 to 1 mg/ml) until achieving a homogenous solution. Three different supports (paper, cotton fabrics and a piece of polyethylene cloth) were soaked with the solution as defined above. After complete evaporation of the solvent in a dark environment, the grafting reaction is carried out by two ways:

a) a thermal activation at a temperature ranging from 200°C to 250°C during a time ranging from 1 to 10 mn (for paper or cotton); and

b) a UV irradiation activation at a wavelength of about 365 nm (for paper, cotton or polyethylene cloth).

After the grafting step, the materials are rinsed with acetone, sonicated and dried. 3.2. from charged arylazide porphyrin (compound 7)

The compound 7 was dissolved in milliQ^® water (0.1 to 1 mg/ml) until achieving a homogenous solution. Three different supports (paper, cotton fabrics and polyethylene cloth) were soaked with the solution as defined above.

After complete evaporation of the solvent in a dark environment, the grafting reaction is carried out by two ways:

b) a UV irradiation activation at a wavelength of about 365 nm (for paper, cotton or a piece of polyethylene cloth). After the grafting step, the materials are rinsed with acetone, sonicated and dried. 3.3. from a mixture of neutral and charged arvlazide porphyrin (compounds 3 and 7)

First, the compound 3 was dissolved in acetone (0.1 to 1 mg ml) until achieving a homogenous solution. The support (cotton fabrics) was soaked with the solution as defined above. After complete evaporation of the solvent in a dark environment, the grafting reaction is implemented on the cotton fabrics by thermal activation at a temperature ranging from 200°C to 250°Cduring a time ranging from 1 min to 10 min. Then, the support is rinsed with acetone, sonicated and dried.

Second, the compound 7 was dissolved in milliQ^® water (0.1 to 1 mg/ml) until achieving a homogenous solution. The support previously modified by the grafting of compound 3, was soaked with the solution comprising the compound 7. After complete evaporation of the solvent in a dark environment, the grafting reaction is implemented on the soaked support by thermal activation (200-250°C) during a time period ranging from 1 to 10 min. Then, the final material is rinsed with water, sonicated and dried.

Example 4: Characterization of the materials of the invention 4.1. UV-visible titration

The materials (cotton fabrics modified by the grafting of either the compound 3 or the compound 7) were dissolved in a hot and concentrated sulfuric acid solution.

Then, a UV-visible titration of the dissolved compounds 3 and 7 was carried out in the resulting solution. The result for the grafting of compound 3 on the cotton fabrics by the process of the invention is about 0.008 μmol/mg of support. The obtained value for compound 7 is about 0.025 μmol/mg of support.

4.2. DRUV technology

The presence and the integrity of the compounds 3 and 7 after grafting on the support were measured by DRUV technology with an integration sphere. DRUV spectra of porphyrin-modified samples were obtained with a CARY 5000 Varian spectrometer using a 110 mm PTFE integrating sphere. Reflectance spectra were recorded against Teflon standard reflectance spectrum. Each spectrum was recorded in the range 350-750 nm. Three supports were studied: cotton fabrics, Whatman paper and a piece of polyethylene cloth.

The results are shown in Figure 1.

For each of the supports, the corresponding spectra shows the presence of Soret bands that corresponds to the high absorbing zone of porphyrin compounds in the blue-violet visible wavelength.

Thus, these results evidence that the process of the invention is efficient for grafting arylazide porphyrin (neutral or charged) on a support such as cotton fabrics, Wathman paper or a piece of polyethylene cloth.

PART 2 - BIOLOGY Example 5: Microbiologic tests

The aim of these experiments is to evidence that the materials of the invention have bactericidal properties.

5.1. Conditions

The following bacterial strains have been studied:

(a) Escherichia Coli BL21 star™ (Gram -);

(b) Bacillus thuringiensis, vegetative form and spore (Gram +);

(c) Salmonella typhimurium CD? 104474 (Gram -);

(d) Yersinia pestis (Gram -);

(e) Bacillus anthracis vegetative form and spore (Gram +). Preculture

Bacteria were previously isolated in a Luria-Bertani plate with gelatin. Bacteria were collected and incubated overnight at 37°C under stirring in a suitable culture medium (Luria-Bertani or Tryptic Soy Borth). Culture

The bacteria culture is used for contacting the materials to study. A dilution (1/200) of the preculture is carried out in a suitable culture medium (Luria-Bertani or Tryptic Soy Borth).

The culture is then incubated at 37°C under stirring during a time period ranging from 2h to 3h until achieving an optic density at 600 nm, ranging from 0.4 to 0.7.

The culture is then diluted again in order to achieve 10⁶ CFU/mL (colony forming unit).

Infection

The materials of the invention to be studied, under the form of disks, were contaminated with:

(a) 40 of the culture at 10⁶ CFU/mL when the support is cotton fabrics or paper; or

(b) 20 μL of the culture at 10⁶ CFU/mL when the support is a piece of polyethylene cloth.

The Petri plates comprising the contaminated disks were incubated an incubator Lexman Light 230 V, E14, 470 Lumen, during 24h at 30°C.

Controls

For each bacteriological test, the following conditions were studied:

(i) Ungrafted disk (UD) kept in a dark environment (Dark) ;

(ii) Ungrafted disk (UD) exposed to light (Light);

(iii) Grafted disk (GD) kept in a dark environment (Dark) ; and

(iv) Grafted disk (GD) exposed to light (Light); (v) a positive control (without incubation); and

(vi) a negative control (without bacteria).

Extraction

Each disk is introduced in an Eppendorf^® vial containing 1 mL of PBS buffer. An incubation is carried out during 30 min at room temperature under mild stirring and in a dark environment.

Enumeration

For each disk, an enumeration of the bacteria colonies was realized.

5.2. Results 5.2.1. for compound 3-grafted materials a) microbiologic results

The microbiologic results for materials grafted with compound 3 after irradiation to LED light at 4000K are presented in Table 1.

Table 1. Microbiologic results for the materials of the invention.

At the beginning of these experiments, the number of bacteria for each infected materials is 10⁶ CFU/mL. After 24h of irradiation to LED light, the materials of the invention have an amount of bacteria equals to 0 CFU/mL. All the tests were performed under the AATCC Test Method 100 1999 "Assessment of Antibacterial finishes on textiles".

Thus, these results evidence that the materials of the invention grafted with neutral aryl azide porphyrin, have bactericidal effect on both bacteria Gram + and bacteria Gram -. b) Bactericidal kinetic results

The bactericidal kinetic has been also studied for a support made of cotton fabrics and grafted with compound 3 by irradiation to LED light.

The results (Table 2) show that for each bacterial strain:

(a) a total bactericidal effect is obtained for a LED irradiation period time of about 4h;

(b) a partial bactericidal effect is obtained for a LED irradiation period time ranging from lh to less than 4h; and

(c) no bactericidal effect is achieved when the LED irradiation period time is about lh.

Table 2. Bactericidal kinetics for cotton fabrics grafted with compound 3 during different light irradiation time periods.

Thus, these results evidence that the materials of the invention allows achieving a bactericidal effect which may be modulated depending on the LED irradiation time period.

5.2.2. for compound 7-grqfted materials a) microbiologic results after LED irradiation

The microbiologic results are presented in Table 3 for cotton fabrics grafted with a cationic aryl azide porphyrin (compound 7) at a concentration equal to 0.2 mg/ml or 1 mg/mL, and after different irradiation time periods to LED light.

Table 3. Bactericidal effects for cotton fabrics grafted with compound 7 at different concentrations and during different LED irradiation time periods.

The results show that bactericidal effects are achieved for cotton fabrics grafted with cationic aryl azide porphyrin.

This effect is total against E. Coli after a LED irradiation of 24h. When the concentration of the porphyrin solution is equal to about 1 mg/mL, a total bactericidal effect against E. Coli is achieved faster than when the concentration of the porphyrin solution is equal to about 0.2 mg/mL; especially, the irradiation time period is reduced to lh. The bactericidal effect against B. thuringiensis is achieved as soon as 30 min after the beginning of the irradiation, when the concentration of the porphyrin solution is 0.2 mg/mL. This irradiation time period is reduced to 20 min when the concentration of the porphyrin solution is 1 mg/mL. b) microbiologic results after natural light irradiation

The microbiologic results are presented in Table 4 for cotton fabrics grafted with compound 7 (cationic aryl azide porphyrin) after irradiation to natural light.

Table 4. Bactericidal effect for cotton fabrics grafted with compound 7 during different natural light irradiation time periods.

The results show that from a cotton fabrics grafted with a charged aryl azide porphyrin (compound 7), a total bactericidal effect may be achieved for an irradiation time period less than 4h. Furthermore, the cotton fabrics grafted with compound 7 is particularly efficient against B. thuringiensis for which the irradiation time period is reduced to 5 min.

Claims

1. A process for manufacturing a biocide and/or bactericidal material comprising:

(ii) contacting the solution obtained at step (i) and a unmodified support, thereby resulting in depositing the arylazide functionalized-photosensitizer on the support; and

2. The process according to claim 1, wherein the arylazide functionalized- photosensitizer is selected from the group of unmetalled arylazide functionalized- photosensitizer.

3. The process according to claim 1 or claim 2, wherein the arylazide functionalized- photosensitizer is selected from tetrapyrrolic compounds such as porphyrins, chlorins, phthalocyanines, benzoporphyrins, bacteriochlorins, chlorophyll derivatives, corroles, texaphyrins, pheophorbides and bacteriopheophorbides; or non tetrapyrrolic compounds such as phenalenones, xanthenes, coumarins, psoralens, antraquinones, curcuminoids, phenothiazines and cyanines.

4. The process according to anyone of claims 1 to 3, wherein the arylazide functionalized-photosensitizer is selected from arylazide porphyrins.

5. The process according to anyone of claims 1 to 4, wherein the concentration of the azide functionalized-photosensitizer solution ranges from more than 0 to lO mg/mL; preferably, from 0.01 to 5 mg/mL; more preferably, from 0.1 to 1 mg/mL.

6. The process according to anyone of claims 1 to 5, wherein the solvent of the arylazide functionalized-photosensitizer solution is selected from polar solvent; preferably, is acetone or water.

7. The process according to anyone of claims 1 to 6, wherein the unmodified support is selected from synthetic or natural polymer, preferably from a polymer selected from the group of polystyrene, polyacrylates, polymethacrylates, polyolefins, polyurethanes, polyacrylonitriles, polyamides, polyesters, polycarbonates, polyethers, polyimides, polyketones, polysiloxanes, polyepoxydes and their copolymers and/or mixtures thereof or cellulosic polymer; more preferably, the unmodified support is paper, cotton fabrics or polyethylene.

8. The process according to anyone of claims 1 to 7, wherein the thermal activation of the insertion reaction is carried out at a temperature ranging from 100°C to 300°C; more preferably, from 200°C to 250°C.

9. The process according to anyone of claims 1 to 8, wherein the UV irradiation activation of the insertion reaction is carried out at a wavelength ranging from 10 nm to 400 nm; preferably, from 300 nm to 380 nm; more preferably, the wavelength is about 365 nm.

10. The process according to anyone of claims 1 to 9, wherein the UV irradiation activation of the insertion reaction is carried out during a time period ranging from 1 mn to 24h; preferably, the UV irradiation activation of the insertion reaction is carried out during a time period ranging from 1 min to 10 min.

11. A biocide and/or bactericidal material comprising:

(b) at least one arylazide-functionalized photosensitizer; preferably selected from tetrapyrrolic compounds such as porphyrins, chlorins, phthalocyanines, benzoporphyrins, bacteriochlorins, chlorophyll derivatives, corroles, texaphyrins, pheophorbides and bacteriopheophorbides; or non tetrapyrrolic compounds such as phenalenones, xanthenes, coumarins, psoralens, antraquinones, curcuminoids, phenothiazines and cyanines; more preferably selected form porphyrins; said arylazide-functionalized photosensitizer being covalently grafted to the support through an insertion bond.

12. Use of the biocide and/or bactericidal material according to claim 11, in the preparation of clothes or coatings; preferably, in the preparation of protective clothes or protective coatings.

13. Use of the biocide and/or bactericidal material according to claim 11, in the decontamination of water and/or biological fluids and/or biological surfaces.

14. A kit comprising :

— in a second compartment, the solution comprising at least one arylazide- functionalized photosensitizer.

15. The kit according to claim 14, wherein the solution comprising at least one arylazide-functionalized photosensitizer is protected from light.